Leukoplakia clinical trials at UCSD
1 in progress, 0 open to new patients

• Pembrolizumab in Treating Participants With Leukoplakia

  Sorry, not yet accepting patients

  This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

  La Jolla, California and other locations

Last updated: October 22, 2018